Anzeige
Mehr »
Login
Donnerstag, 12.09.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Lachender Gewinner? Warum diese Rohstoffaktie alles überstrahlen könnte!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
261 Leser
Artikel bewerten:
(1)

Intracranial Pressure (ICP) Monitoring Market to Reach $0.6 Billion, Globally, by 2033 at 5.1% CAGR: Allied Market Research

Rise in incidence of traumatic brain injuries (TBIs), rise in demand for minimally invasive procedures, and increase in geriatric population are the major factors which drive the global market growth

WILMINGTON, Del., Aug. 14, 2024 /PRNewswire/ -- Allied Market Research published a report, titled, "Intracranial Pressure (ICP) Monitoring Market by Technique (Invasive and Non-Invasive), Application (Traumatic Brain Injury, Intracerebral Hemorrhage, Meningitis, and Others), and End User (Hospital, Clinics, Private Medical Offices, Trauma Centers and Government and Research Organizations): Global Opportunity Analysis and Industry Forecast, 2024-2033". According to the report, the intracranial pressure (ICP) monitoring market was valued at $0.4 billion in 2023, and is estimated to reach $0.6 billion by 2033, growing at a CAGR of 5.1% from 2024 to 2033.

Allied_Market_Research_Logo

Request Sample of the Report on Intracranial Pressure (ICP) Monitoring Market Forecast 2033 - https://www.alliedmarketresearch.com/request-sample/A149770

Prime determinants of growth

Rise in prevalence of traumatic brain injuries (TBIs) , rise in demand for minimally invasive procedures and increase in geriatric population are the major factors that drive the growth of the intracranial pressure monitoring market growth. However, high costs of devices hinder the market growth. Moreover, technological advancements and untapped markets in developing economies offer remunerative opportunities for the expansion of the global intracranial pressure monitoring market.

Report coverage & details

Report Coverage

Details

Forecast Period

2024-2033

Base Year

2023

Market Size in 2023

$0.4 billion

Market Size in 2033

$0.6 billion

CAGR

5.1 %

No. of Pages in Report

216

Segments Covered

Technique, Application, End User, and Region

Drivers

Rise in incidence of traumatic brain injuries (TBIs)

Rise in demand for minimally invasive procedures

Increase in geriatric population

Opportunities

Technological advancements

Untapped markets in developing economies

Restraints

High costs of devices

Have a Question? Connect to our Analyst - https://www.alliedmarketresearch.com/connect-to-analyst/A149770

Segment Highlights

The non-invasive segment to maintain its leadership status during the forecast period

By technique, the non-invasive segment generated the highest revenue in the intracranial pressure market in 2023. The increasing preference for non-invasive intracranial pressure monitoring devices is driven by their ability to provide accurate measurements without the need for invasive procedures, reducing patient discomfort and complications. These devices offer real-time monitoring capabilities and are often more cost-effective than invasive methods, making them attractive options for healthcare providers seeking safer and more patient-friendly alternatives for intracranial pressure assessment.

The traumatic brain injury segment to maintain its leadership status during the forecast period

By application, the traumatic brain injury segment generated the highest revenue in the intracranial pressure market in 2023. The rise in the prevalence of traumatic brain injury, intracerebral hemorrhage, and meningitis is driving the demand for intracranial pressure monitoring. These conditions can lead to elevated intracranial pressure, which, if left untreated, can result in severe neurological complications and even death. As healthcare providers strive to improve patient outcomes and minimize the risk of secondary brain injuries, there is a growing need for timely and accurate intracranial pressure monitoring to guide treatment decisions and optimize patient care.

The hospitals segment to maintain its leadership status during the forecast period

By end user, the hospitals segment generated the highest revenue in the intracranial pressure market in 2023. Hospitals are the primary users of intracranial pressure monitoring devices due to their role as major healthcare providers, offering comprehensive neurocritical care services and specialized equipment for monitoring and managing patients with traumatic brain injuries, strokes, and other neurological conditions.

For Purchase Related Queries/Inquiry - https://www.alliedmarketresearch.com/purchase-enquiry/A149770

Regional Outlook

In North America, the intracranial pressure monitoring market thrives owing to their sophisticated healthcare systems, high prevalence of chronic diseases, and widespread access to healthcare services. These regions also boast substantial research and development efforts, resulting in continuous advancements in intracranial pressure monitoring technology. Conversely, emerging markets such as Asia-Pacific and LAMEA are witnessing rapid growth in this sector due to escalating healthcare spending and the expansion of pharmaceutical industries.

Key Players

  • AMETEK
  • Elekta AB
  • Koninklijke Philips N.V.
  • Smiths Medical
  • Sick AG
  • Teleflex Incorporated
  • GE Healthcare
  • Integra LifeSciences
  • Natus Medical Incorporated
  • BrainLAB.

The report provides a detailed analysis of these key players in the global intracranial pressure monitoring market. These players have adopted different strategies such as clinical trials, product launch and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.

Recent Industry Development

  • In March 2021, Longeviti Neuro Solutions, a MedTech company developing innovative solutions for complex brain surgery, announced the launch of the Longeviti ClearFit Cover. The first-of-its-kind sonolucent ClearFit Cover is used to replace excised cranial bone following a neurosurgical procedure, enabling neurosurgeons to use ultrasound imaging to view neuroanatomy after brain surgery, and allowing long-term monitoring of their patients' condition.
  • In April 2021, a clinical trial studying 'intracranial pressure monitoring device performed in non-invasive method' developed by Brain4Care is under trial. This technology allows non-invasive assessment of the patient's status, which decreases a major risk of adverse effects while also lowering the expense of monitoring.

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int'l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/intracranial-pressure-icp-monitoring-market-to-reach-0-6-billion-globally-by-2033-at-5-1-cagr-allied-market-research-302222108.html

© 2024 PR Newswire
Vorsicht Crash! So sichere ich mein Aktienportfolio aktiv ab

Der schwarze Montag Anfang August, in Folge der temporären Liquidierung des sogenannten „Yen Carry-Trades“, vernichtete Milliarden an Anlegergeldern. Sogenannte Black Swan Events, also Ereignisse, die nichts und niemand vorhersagen kann, traten zuletzt im März 2020 beim Ausbruch der Corona-Pandemie auf.

Doch wie können Sie sich bei einem derartigen Ausverkauf und Verfall Ihres Depots schützen? Im folgenden kostenlosen Spezialreport wird aufgezeigt, wie man sein Depot mit diversen Strategien und den richtigen Instrumenten versichern kann.

Erweitern Sie Ihr Wissen und handeln Sie zukünftig wie die Profis, um vor dem nächsten schwarzen Schwan ihr Kapital in Sicherheit zu bringen.

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.